EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MicroRNA-181a-5p promotes papillary thyroid carcinoma progress via the PTEN/AKT pathway

Wenyu Zhao, Yiting Guo, Liang He, Junhong Li, Zhenglun Qiu, Haojie Chen, Leilei Li, Hua Wang, Yunlong Wang, Yanfang Zhang

Molecular Biotechnology · 2026

DOI: 10.1007/s12033-026-01581-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biotechnology, 2026. Verfasst von Wenyu Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471009, Henan Province, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, PTEN Phosphohydrolase, Proto-Oncogene Proteins c-akt, Thyroid Cancer, Papillary. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative leading talents of science and technology project of Health Commission of Henan Province, Medical key project of Luoyang City, Graduate research innovation program of Xinxiang Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this investigation was to determine the expression profile and latent mechanism of microRNA-181a-5p (miR-181a-5p) in the genesis and progression of papillary thyroid cancer (PTC). MiR-181a-5p was discovered to be upregulated in PTC tissues and cells in this study, as confirmed by RT‒qPCR and The Cancer Genome Atlas database. Notably, in PTC patients, the miR-181a-5p level was linked to tumor size and thyroid capsule invasion. A series of experiments demonstrated that miR-181a-5p upregulation in PTC cells notably enhanced proliferation, motility, and invasion, whereas suppressing miR-181a-5p hindered these functions. Western blotting revealed that miR-181a-5p suppressed PTEN expression, boosting the activation of phosphorylated AKT (P-AKT). According to predictive bioinformatics research and luciferase reporter gene tests, miR-181a-5p may target a specific binding site on the PTEN 3'UTR. To sum up, this study indicated that miR-181a-5p promoted PTC progression through the PTEN/Akt pathway. This investigation reveals a potential mechanism for PTC progression and provides a foundation for clinical therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPTEN PhosphohydrolaseProto-Oncogene Proteins c-aktThyroid Cancer, PapillaryThyroid NeoplasmsHumansGene Expression Regulation, NeoplasticSignal TransductionCell Line, TumorCell ProliferationCell Movement3' Untranslated RegionsDisease Progression

Stichwörter der Autor:innen

BiomarkerMiR-181a-5pPTENPTEN/Akt pathwayPapillary thyroid cancer

Substanzen

MicroRNAsPTEN PhosphohydrolaseMIrn181 microRNA, humanProto-Oncogene Proteins c-aktPTEN protein, human3' Untranslated Regions

Autor:innen und Institutionen

  • Department of Endocrinology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471009, Henan Province, People's Republic of China.
  • Zhengzhou University, Zhengzhou, 450001, Henan Province, China.
  • Department of Thyroid and Breast Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471009, Henan Province, China.
  • Department of Pathology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471009, Henan Province, China.
  • Department of Cardiology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471009, Henan Province, China.
  • Department of Ultrasound, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471009, Henan Province, China.

Förderung

  • Innovative leading talents of science and technology project of Health Commission of Henan Province
  • Medical key project of Luoyang City
  • Graduate research innovation program of Xinxiang Medical College
  • Henan Provincial Science and Technology Research Project

Zitieren

APA

Zhao, W., Guo, Y., He, L., Li, J., Qiu, Z., Chen, H., Li, L., Wang, H., Wang, Y., & Zhang, Y. (2026). MicroRNA-181a-5p promotes papillary thyroid carcinoma progress via the PTEN/AKT pathway. Molecular Biotechnology. https://doi.org/10.1007/s12033-026-01581-2

Vancouver

Zhao W, Guo Y, He L, Li J, Qiu Z, Chen H, et al. MicroRNA-181a-5p promotes papillary thyroid carcinoma progress via the PTEN/AKT pathway. Molecular Biotechnology. 2026. doi:10.1007/s12033-026-01581-2

BibTeX
@article{Zhao2026,
  author = {Zhao, Wenyu and Guo, Yiting and He, Liang and Li, Junhong and Qiu, Zhenglun and Chen, Haojie and Li, Leilei and Wang, Hua and Wang, Yunlong and Zhang, Yanfang},
  title = {MicroRNA-181a-5p promotes papillary thyroid carcinoma progress via the PTEN/AKT pathway},
  journal = {Molecular Biotechnology},
  year = {2026},
  doi = {10.1007/s12033-026-01581-2}
}
Kostenlos starten →